Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-25T01:47:33.775Z Has data issue: false hasContentIssue false
  • English
  • Français

Endothelial Cells Organize Fibrin Clots into Structures That Are More Resistant to Lysis

Published online by Cambridge University Press:  12 May 2005

W. Gray Jerome ,
Stefan Handt  and
Roy R. Hantgan
W. Gray Jerome
Affiliation:
Departments of Pathology and Cancer Biology, U-2206 MCN, Vanderbilt University School of Medicine, Nashville, TN 37232-2561, USA
Stefan Handt
Affiliation:
Institute of Pathology, Aachen University of Technology, D-52072 Aachen, Germany Present address: Institut für Pathologie, Bonn-Duisdorf, Heilsbachstraße 15, D-53123 Bonn, Germany.
Roy R. Hantgan
Affiliation:
Department of Biochemistry, Wake Forest University Health Sciences Center, Winston-Salem, NC 27157, USA
Get access

Abstract

Acute myocardial infarction is a major cause of death and disability in the United States. Introducing thrombolytic agents into the clot to dissolve occlusive coronary artery thrombi is one method of treatment. However, despite advances in our knowledge of thrombosis and thrombolysis, survival rates following thrombolytic therapy have not improved substantially. This failure highlights the need for further study of the factors mediating clot stabilization. Using laser scanning confocal microscopy of clots formed from fluorescein-labeled fibrinogen, we investigated what effect binding of fibrin to the endothelial surface has on clot structure and resistance to lysis. Fluorescent fibrin clots were produced over human umbilical vein endothelial cells (HUVEC) and the clot structure analyzed. In the presence of HUVEC, fibrin near the endothelial surface was more organized and occurred in tighter bundles compared to fibrin just 50 μm above. The HUVEC influence on fibrin architecture was blocked by inhibitory concentrations of antibodies to αV or β3 integrin subunits. The regions of the clots associated with endothelial cells were more resistant to lysis than the more homogenous regions distal to endothelium. Thus, our data show that binding of fibrin to integrins on endothelial surfaces produces clots that are more resistant to lysis.

Keywords

thrombosisfibrinolysisfibrinendothelial cellsintegrinsconfocal microscopy
Type
Research Article
Information
Microscopy and Microanalysis , Volume 11 , Issue 3 , June 2005 , pp. 268 - 277
Copyright
© 2005 Microscopy Society of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Anderson, H. & Willerson, J. (1993). Thrombolysis in acute myocardial infarction. New Eng J Med 329, 703–709.Google Scholar
Bett, J.H. (1997). Interventional management of acute myocardial infarction (AMI). Aust N Z J Med 27, 504–509.Google Scholar
Booth, N., Simpson, A., Croll, A., Bennett, B., & MacGregor, I. (1988). Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Brit J Haemotol 70, 327–333.Google Scholar
Braaten, J.V., Jerome, W.G., & Hantgan, R.R. (1994). Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface. Blood 83, 982–993.Google Scholar
Chang, M., Wang, B., & Huang, T. (1995). Characterization of endothelial cell differential attachment to fibrin and fibrinogen and its inhibition by Arg-Gly-Asp-containing peptides. Thromb Haemost 74, 764–769.Google Scholar
Cheresh, D.A., Berliner, S.A., Vicente, V., & Ruggeri, Z.M. (1989). Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 58, 945–953.Google Scholar
Cohen, M., Arjomand, H., & Pollack, C. (2004). The evolution of thrombolytic therapy and adjunctive antithrombotic regimens in acute ST-segment elevation myocardial infarction. Am J Emerg Med 22, 14–23.Google Scholar
Collen, D. & Lijnen, H.R. (1995). Molecular basis of fibrinolysis, as relevant for thrombolytic therapy. Thromb Haemost 74, 167–171.Google Scholar
Collet, J.-P., Lesty, C., Montalescot, G., & Weisel, J. (2003). Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots. J Biol Chem 278, 21331–21335.Google Scholar
Conforti, G., Dominguez-Jimenez, C., Zanetti, A., Gimbrone, M.A., Jr., Cremona, O., Marchisio, P.C., & Dejana, E. (1992). Human endothelial cells express integrin receptors on the luminal aspect of their membrane. Blood 80, 437–446.Google Scholar
Dejana, E. (1993). Endothelial cell adhesive receptors. J Cardiovasc Pharmacol 21, S18–S21.Google Scholar
Forester, J. (1995). New standard for success of thrombolytic therapy: An earnest proposal. Circulation 92, 2026–2028.Google Scholar
Group, F.C. (1994). Indication for fibrinolytic therapy in suspected acute myocardial infraction: Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 343, 311–322.Google Scholar
Handt, S., Jerome, W., Braaten, J., Lewis, J., Kirkpatrick, C., & Hantgan, R. (1994). PAI-1 released from cultured human endothelial cells delays fibrinolysis and is incorporated into the developing fibrin clot. Fibrinolysis 8, 104–112.Google Scholar
Handt, S., Jerome, W.G., Tietze, L., & Hantgan, R.R. (1996). Plasminogen activator inhibitor-1 secretion of endothelial cells increases fibrinolytic resistance of an in vitro fibrin clot: Evidence for a key role of endothelial cells in thrombolytic resistance. Blood 87, 4204–4213.Google Scholar
Hantgan, R. (1987). An investigation of platelet-fibrin adhesive interactions by microfluorimetry. Biochim Biophys Acta 927, 55–64.Google Scholar
Hantgan, R., Jerome, W., & Handt, S. (1998). Platelets and endothelial cells act in concert to delay thrombolysis. Evidence from an in vitro model of the human occlusive thrombus. Thromb Haemost 79, 602–608.Google Scholar
Henneckens, C. (1997). The need for wider utilization of thrombolytic therapy. Clin Cardiol 20 (suppl 3): III26–III31.Google Scholar
Jaffe, E., Nachman, R., Becker, C., & Minick, C. (1973). Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52, 2745–2756.Google Scholar
Jerome, W. & Handt, S. (1998). Endothelium and matrix interactions. In Modern Visualization of the Endothelium, Polak, J. (Ed.), pp. 93–112. Amsterdam: Harwood Academic Publishers.
Le Breton, H., Plow, E., & Topol, E. (1996). Role of platelets in restenosis after percutaneous coronary revascularization. J Am Coll Cardiol 28, 1643–1651.Google Scholar
Lendon, C., Born, G., Davies, M., & Richardson, P. (1992). Plaque fissure: The link between atherosclerosis and thrombosis. Nouv Rev Fr Hematol 34, 27–29.Google Scholar
Milei, J., Parodi, J.C., Fernandez Alonso, G., Barone, A., Beigelman, R., Ferreira, L.M., Arrigoni, G., & Matturri, L. (1996). Carotid atherosclerosis. Immunocytochemical analysis of the vascular and cellular composition in endarterectomies. Cardiologia 41, 535–542.Google Scholar
Qi, J., Goralnick, S., & Kreutzer, D. (1997). Fibrin regulation of interleukin-8 gene expression in human vascular endothelial cells. Blood 90, 3595–3602.Google Scholar
Sakharov, D., Nagelkerke, J., & Rijken, D. (1996). Rearrangements of fibrin network and spatial distribution of fibrinolytic components during plasma clot lysis. J Biol Chem 271, 2133–2138.Google Scholar
Shattil, S. & Ginsberg, M. (1997). Integrin signaling in vascular biology. J Clin Invest 100, S1–S5.Google Scholar
Smyth, S.S., Joneckis, C.C., & Parise, L.V. (1993). Regulation of vascular integrins. Blood 81, 2827–2843.Google Scholar
Tcheng, J.E. (1996). Glycoprotein IIb/IIIa receptor inhibitors: Putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective. Am J Cardiol 78, 35–40.Google Scholar
Topol, E., Ferguson, J., Weisman, H., Tcheng, J., Ellis, S., Kleinman, N., Ivanhoe, R., Wang, A., Miller, D., Anderson, K., Califf, R., & Group, E.I. (1997). Long-term protection from myocardial ischemic events in a randomized trial of brief integrin β3 blockade with percutaneous coronary intervention. J Am Med Assoc 278, 479–484.Google Scholar
Veklich, Y., Francis, C., White, J., & Weisel, J. (1998). Structural studies of fibrinolysis by electron microscopy. Blood 92, 4721–4729.Google Scholar
White, H. (1997). Unmet therapeutic needs in the management of acute ischemia. Am J Cardiol 80, 2B–10B.Google Scholar
White, H. & Vandewerf, F. (1998). Thrombolysis for acute myocardial infarction. Circulation 97, 1632–1646.Google Scholar
Wu, J., Siddiqui, K., & Diamond, S. (1994). Transport phenomena and clot dissolving therapy: An experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis. Thromb Haemost 72, 105–112.Google Scholar
Wu, K.K. & Thiagarajan, P. (1996). Role of endothelium in thrombosis and hemostasis. Annu Rev Med 47, 315–331.Google Scholar